Template:SUIT-008: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
Line 11: | Line 11: | ||
| [[N]] | | [[N]] | ||
| CI | | CI | ||
| | | 1PM | ||
{{Template:SUIT N}} {{Template:SUIT L(n)}} | {{Template:SUIT N}} {{Template:SUIT L(n)}} | ||
Line 22: | Line 22: | ||
| 1PM;2D | | 1PM;2D | ||
{{Template:SUIT N}} {{Template:SUIT OXPHOS}} | *{{Template:SUIT N}} ย | ||
*{{Template:SUIT OXPHOS}} | |||
|- | |- | ||
Line 31: | Line 32: | ||
| 1PM;2D;2c | | 1PM;2D;2c | ||
{{Template:SUIT N}} {{Template:SUIT | *{{Template:SUIT N}} ย | ||
*{{Template:SUIT c}} | |||
*{{Template:SUIT OXPHOS}} ย | |||
ย | |||
|- | |- | ||
Line 40: | Line 44: | ||
| 1PM;2D;2c;3G | | 1PM;2D;2c;3G | ||
{{Template:SUIT N}} {{Template:SUIT OXPHOS}} | *{{Template:SUIT N}} ย | ||
*{{Template:SUIT OXPHOS}} | |||
|- | |- | ||
Line 49: | Line 54: | ||
| 1PM;2D;2c;3G;4S | | 1PM;2D;2c;3G;4S | ||
{{Template:SUIT N}} | *{{Template:SUIT N}} ย | ||
*{{Template:SUIT S}} ย | |||
*{{Template:SUIT NS}} ย | |||
*{{Template:SUIT OXPHOS}} | |||
|- | |- | ||
Line 58: | Line 66: | ||
| 1PM;2D;2c;3G;4S;5U | | 1PM;2D;2c;3G;4S;5U | ||
{{Template:SUIT N}} | *{{Template:SUIT N}} | ||
*{{Template:SUIT S}} ย | |||
*{{Template:SUIT NS}} | |||
*{{Template:SUIT U*}} | |||
*{{Template:SUIT ET}} | |||
|- | |- | ||
Line 67: | Line 79: | ||
| 1PM;2D;2c;3G;4S;5U;6Rot | | 1PM;2D;2c;3G;4S;5U;6Rot | ||
{{Template:SUIT Rot}} {{Template:SUIT ET}} | *{{Template:SUIT S}} | ||
*{{Template:SUIT Rot}} ย | |||
*{{Template:SUIT ET}} | |||
*The addition of [[rotenone]] will depend on the experimental question to resolve. | |||
|- | |- | ||
Line 74: | Line 89: | ||
| ย | | ย | ||
|ย ย | |ย ย | ||
| | | 1PM;2D;2c;3G;4S;5U;6Rot;7Ama | ||
*{{Template:SUIT Ama}} | |||
*{{Template:SUIT ROX}} | |||
*The addition of [[rotenone]] or [[Antimycin A]] will depend on the experimental question to resolve. | |||
|} | |} | ||
{{Template:SUIT CIV}} | {{Template:SUIT CIV}} | ||
{{Template:Keywords in SUIT protocols}} | {{Template:Keywords in SUIT protocols}} |
Revision as of 10:33, 28 January 2019
Steps and respiratory states
Step | State | Pathway | Q-junction | Comment - Events (E) and Marks (M) |
---|---|---|---|---|
1PM | PML | N | CI | 1PM
NADH-linked substrates (type N-pathway to Q). Non-phosphorylating resting state (LEAK state); LEAK respiration L(n) in the absence of ADP, ATP, AMP (no adenylates). |
2D | PMP | N | CI | 1PM;2D
|
2c | PMcP | N | CI | 1PM;2D;2c
|
3G | PGMP | N | CI | 1PM;2D;2c;3G
|
4S | PGMSP | NS | CI&II | 1PM;2D;2c;3G;4S
|
5U | PGMSE | NS | CI&II | 1PM;2D;2c;3G;4S;5U
|
6Rot | SE | S | CII | 1PM;2D;2c;3G;4S;5U;6Rot
|
7Ama | ROX | 1PM;2D;2c;3G;4S;5U;6Rot;7Ama
|
Step | Respiratory state | Pathway control | ET-Complex | Comment |
---|---|---|---|---|
## AsTm | AsTmE | CIV | CIV | |
## Azd | CHB |
- Bioblast links: SUIT protocols - >>>>>>> - Click on [Expand] or [Collapse] - >>>>>>>
- Coupling control
- Pathway control
- ยป Electron transfer pathway
- ยป Fatty acid oxidation pathway control state, F
- ยป NADH electron transfer-pathway state, N
- ยป Succinate pathway control state, S
- ยป NS-pathway control state, NS
- ยป Glycerophosphate pathway control state, Gp
- ยป Complex IV single step, CIV
- ยป Anaplerotic pathway control state
- Pathway control
- Main fuel substrates
- ยป Glutamate, G
- ยป Glycerophosphate, Gp
- ยป Malate, M
- ยป Octanoylcarnitine, Oct
- ยป Pyruvate, P
- ยป Succinate, S
- Main fuel substrates
- Glossary